Bank of New York Mellon Corp reduced its stake in Aetna Inc. (NYSE:AET) by 1.7% in the 3rd quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 4,277,392 shares of the company’s stock after selling 75,516 shares during the quarter. Bank of New York Mellon Corp owned about 1.31% of Aetna worth $680,149,000 as of its most recent SEC filing.
Other institutional investors also recently made changes to their positions in the company. Bruderman Asset Management LLC purchased a new position in shares of Aetna in the 2nd quarter valued at approximately $106,000. Lloyds Banking Group plc purchased a new position in shares of Aetna in the 3rd quarter valued at approximately $106,000. Moisand Fitzgerald Tamayo LLC purchased a new position in shares of Aetna in the 3rd quarter valued at approximately $116,000. Liberty Capital Management Inc. raised its position in shares of Aetna by 206.9% in the 2nd quarter. Liberty Capital Management Inc. now owns 933 shares of the company’s stock valued at $144,000 after purchasing an additional 629 shares during the last quarter. Finally, Westside Investment Management Inc. raised its position in shares of Aetna by 53.5% in the 2nd quarter. Westside Investment Management Inc. now owns 1,148 shares of the company’s stock valued at $177,000 after purchasing an additional 400 shares during the last quarter. 90.93% of the stock is owned by hedge funds and other institutional investors.
Several brokerages recently commented on AET. Cantor Fitzgerald reaffirmed a “neutral” rating and issued a $175.00 price objective on shares of Aetna in a research report on Monday, October 23rd. Citigroup Inc. increased their price objective on shares of Aetna from $183.00 to $197.00 and gave the company a “buy” rating in a research report on Thursday, November 2nd. Zacks Investment Research lowered shares of Aetna from a “buy” rating to a “hold” rating in a research report on Tuesday, October 3rd. Argus reaffirmed a “buy” rating and issued a $185.00 price objective (up from $165.00) on shares of Aetna in a research report on Tuesday, September 12th. Finally, BidaskClub lowered shares of Aetna from a “strong-buy” rating to a “buy” rating in a research report on Wednesday, July 19th. Eleven equities research analysts have rated the stock with a hold rating and fourteen have given a buy rating to the company’s stock. Aetna currently has a consensus rating of “Buy” and a consensus target price of $170.34.
In other news, EVP Margaret M. Mccarthy sold 10,288 shares of the stock in a transaction that occurred on Friday, September 15th. The stock was sold at an average price of $162.85, for a total transaction of $1,675,400.80. Following the transaction, the executive vice president now owns 33,563 shares in the company, valued at approximately $5,465,734.55. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Also, President Karen S. Lynch sold 15,271 shares of the stock in a transaction that occurred on Monday, September 18th. The shares were sold at an average price of $161.91, for a total value of $2,472,527.61. Following the transaction, the president now owns 64,261 shares in the company, valued at approximately $10,404,498.51. The disclosure for this sale can be found here. Company insiders own 1.14% of the company’s stock.
Shares of Aetna Inc. (NYSE AET) traded down $2.10 during midday trading on Tuesday, hitting $173.02. 2,193,300 shares of the stock were exchanged, compared to its average volume of 2,446,281. The firm has a market cap of $57,106.63, a PE ratio of 17.15, a price-to-earnings-growth ratio of 1.60 and a beta of 0.61. Aetna Inc. has a twelve month low of $116.04 and a twelve month high of $184.98. The company has a quick ratio of 0.53, a current ratio of 0.53 and a debt-to-equity ratio of 0.52.
Aetna (NYSE:AET) last announced its earnings results on Tuesday, October 31st. The company reported $2.45 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.06 by $0.39. Aetna had a return on equity of 21.84% and a net margin of 2.93%. The firm had revenue of $14.99 billion for the quarter, compared to analyst estimates of $15.12 billion. During the same quarter last year, the firm posted $2.07 EPS. The business’s revenue was down 5.0% on a year-over-year basis. equities analysts forecast that Aetna Inc. will post 9.78 EPS for the current year.
The firm also recently announced a quarterly dividend, which was paid on Friday, October 27th. Stockholders of record on Thursday, October 12th were given a dividend of $0.50 per share. The ex-dividend date of this dividend was Wednesday, October 11th. This represents a $2.00 dividend on an annualized basis and a dividend yield of 1.16%. Aetna’s dividend payout ratio (DPR) is 37.04%.
Aetna Inc is a diversified healthcare benefits company. The Company operates through three segments: Health Care, Group Insurance and Large Case Pensions. It offers a range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental, behavioral health, group life and disability plans, medical management capabilities, Medicaid healthcare management services, Medicare Advantage and Medicare Supplement plans, workers’ compensation administrative services and health information technology (HIT) products and services.
Want to see what other hedge funds are holding AET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Aetna Inc. (NYSE:AET).
Receive News & Ratings for Aetna Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aetna Inc. and related companies with MarketBeat.com's FREE daily email newsletter.